Last data update:
20 October 2018 04:23 CEST
|Name:||pDG2i-eGFP-V5 blast Add to cart|
|Accession number:||LMBP 9174|
|Sequence file:||Depositor's sequence: p9174.gb View with Genome Compiler|
|Status:||LMBP non-core plasmid|
|Cloned DNA:||Aequorea victoria green fluorescent protein DNA (GFP); enhanced red-shifted variant (EGFP), C-terminal
Reverse tetracycline-responsive transcriptional activator (rtTA); variant 3 (rtTA3)
B gene of the control of cell death locus of the Escherichia coli F plasmid (ccdB, lethal gene)
V5 epitope; C-terminal
|Promoter:||Human cytomegalovirus immediate early promoter (CMV-IE); minimal promoter with tet responsive element (CMVTRE)
Rous sarcoma virus/human immunodeficiency virus hybrid long terminal repeat (RSV/HIV-1 5' LTR)
Simian virus 40 early promoter (SV40 early)
Escherichia coli lac operon promoter
Phage T7 gene 10 promoter (T7g10)
Phage T3 promoter
Escherichia coli lac operon promoter; mutant (lacUV5)
|Internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV) polyprotein gene|
|Terminator:||Simian virus 40 polyadenylation signal (SV40 polyA)
Rous sarcoma virus/human immunodeficiency virus hybrid long terminal repeat (RSV/HIV-1 3' LTR); modified HIV-1 3' LTR with deleted U3 region (ΔU3/3' LTR)
|Selection marker:||Ampicillin (amp)
|Replicon:||Simian virus 40 bidirectional origin (SV40)
Escherichia coli plasmid pMB1 origin
Phage f1 origin
|Host range:||Escherichia coli; use a ccdB-resistant strain for propagation
Mammalian cells; SV40 permissive cells
|Parental clone:||pDG2i-eGFP-V5 puro|
|Further information:||The plasmid was constructed by replacing the puromycin resistance coding sequence in pDG2i-eGFP-V5 puro with the blasticidin resistance coding sequence.
This is a lentiviral Gateway destination vector, with the tet-inducible minimal human CMV-IE promotor and rtTA3 on the same plasmid.
The plasmid is suitable for microRNA expression.
The U3 region of the HIV-1 3' LTR is deleted (ΔU3 or dU3) and facilitates self-inactivation of the HIV-1 5' LTR after transduction to enhance the biosafety of the vector. The element also contains a polyadenylation signal for transcription termination and polyadenylation of mRNA in transduced cells.
The vector contains the psi packaging signal, allowing viral packaging, and the rev response element (RRE) from HIV-1, permitting Rev-dependent nuclear export of unspliced viral mRNA.
Depending on the gene cloned in this vector, some leakage expression may be detected.
Because the risk for recombination after each subcultivation is high, this plasmid is only available under the format of isolated plasmid DNA. Plasmid integrity should be checked via PvuII restriction digest after each subcultivation.
This Gateway destination vector is compatible with the human orfeome library which is also available at BCCM/GeneCorner.
This vector can not be used to express short hairpin RNA (shRNA), which requires an RNA-polymerase III promotor. However, this vector can be used for knock-down experiments if the hairpin is expressed in a micro-RNA context (eg. Block-iT PolII miR RNAi kit).
The nucleotide sequence of the parental pDG2i-eGFP-V5 puro vector corresponds with the EMBL Nucleotide Sequence Database accession number LT009443.1.
Other name of the plasmid is pDG2(bla)-EGFP-V5-rtTA3- dest.
|EMBL Accession number:||LT009443.1, view at EMBL, GenBank, DDBJ|
|Latest sequence update:||28/04/2017|
|Authenticity test:||The restriction enzyme pattern has still to be analysed.|
|History of deposit:||This plasmid was deposited by Prof. Dr P. Vandenabeele(1) (2).
(1) Center for Inflammation Research, VIB, Ghent, Belgium
(2) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
|Related plasmid reference:||De Groote et al., BioTechniques 60 (2016), 252-259 [PMID: 27177818] [DOI: 10.2144/000114417]
|Restricted distribution:||- BCCM MTA|
|Distributed as:||plasmid DNA|
|Host for distribution:||Escherichia coli K12xB DB3.1|
|Related host reference:||Bernard et al., J. Mol. Biol. 226 (1992), 735-745 [PMID: 1324324]
|Cultivation medium:||LB-Lennox + ampicillin (100 μg/ml) + chloramphenicol (25 μg/ml)*|
|Biosafety level:||L1 in E. coli; L2 in mammalian cells|
|Cultivation remark:||*: selection of transformants on chloramphenicol; subsequent cultivation of a single colony in liquid medium with ampicillin.|
|Other culture collection numbers:||-|
Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.